We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Scholastic
SCHL
$772M
| $298K | ﹤0.01% |
9,700
-1,900
| -16% | -$79.2K |
|
2052
Steris
STE
$22.7B
| $296K | ﹤0.01% |
1,783
+800
| +81% | +$163K |
|
|
TTM
2053
DELISTED
Tata Motors Limited
TTM
| $296K | ﹤0.01% |
12,200
+3,500
| +40% | +$98.3K |
|
2054
Tilly's
TLYS
$113M
| $295K | ﹤0.01% |
42,700
-27,700
| -39% | -$210K |
|
|
CTEV
2055
Claritev Corp
CTEV
$401M
| $295K | ﹤0.01% |
2,578
| – | – |
|
|
VGR
2056
DELISTED
Vector Group Ltd.
VGR
| $295K | ﹤0.01% |
+33,500
| New | +$340K |
|
|
AAIC
2057
DELISTED
Arlington Asset Investment Corp.
AAIC
| $295K | ﹤0.01% |
108,454
-50,100
| -32% | -$158K |
|
2058
W.W. Grainger
GWW
$64.6B
| $294K | ﹤0.01% |
+600
| New | +$316K |
|
2059
Tower Semiconductor
TSEM
$21.6B
| $294K | ﹤0.01% |
+6,700
| New | +$309K |
|
2060
Sibanye-Stillwater
SBSW
$5.95B
| $291K | ﹤0.01% |
31,200
+3,700
| +13% | +$35.1K |
|
2061
TTM Technologies
TTMI
$10.7B
| $290K | ﹤0.01% |
22,000
-16,800
| -43% | -$242K |
|
2062
Coca-Cola Consolidated
COKE
$13B
| $288K | ﹤0.01% |
7,000
-3,000
| -30% | -$148K |
|
2063
Camtek
CAMT
$6.12B
| $285K | ﹤0.01% |
12,300
-22,500
| -65% | -$610K |
|
2064
Simulations Plus
SLP
$371M
| $282K | ﹤0.01% |
5,800
-1,000
| -15% | -$58.4K |
|
2065
Utah Medical Products
UTMD
$226M
| $282K | ﹤0.01% |
3,300
-2,800
| -46% | -$247K |
|
2066
NWPX Infrastructure Inc
NWPX
$1.18B
| $281K | ﹤0.01% |
+10,000
| New | +$306K |
|
2067
MKS Inc
MKSI
$18B
| $279K | ﹤0.01% |
3,375
-11,825
| -78% | -$1.22M |
|
|
PVBC
2068
DELISTED
Provident Bancorp
PVBC
| $279K | ﹤0.01% |
19,500
-13,300
| -41% | -$198K |
|
|
VTYX
2069
DELISTED
Ventyx Biosciences
VTYX
| $279K | ﹤0.01% |
+8,000
| New | +$177K |
|
2070
Host Hotels & Resorts
HST
$17.4B
| $278K | ﹤0.01% |
+17,500
| New | +$305K |
|
2071
Ribbon Communications
RBBN
$386M
| $278K | ﹤0.01% |
125,400
+19,200
| +18% | +$60.8K |
|
|
SUP
2072
DELISTED
Superior Industries International
SUP
| $278K | ﹤0.01% |
92,182
-19,900
| -18% | -$87.8K |
|
2073
Copart
CPRT
$28.9B
| $277K | ﹤0.01% |
10,400
-19,200
| -65% | -$572K |
|
2074
Dr. Reddy's Laboratories
RDY
$9.85B
| $277K | ﹤0.01% |
26,500
-31,500
| -54% | -$335K |
|
2075
Veracyte
VCYT
$4.44B
| $277K | ﹤0.01% |
16,700
+200
| +1% | +$4.5K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.